Teprotumumab for Inactive Thyroid Eye Disease? The Jury Is Still Out.

被引：0
|
作者：
Dosiou, Chrysoula [1 ,2 ]
机构：
[1] Stanford Univ, Div Endocrinol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Div Endocrinol, Sch Med, 300 Pasteur Dr,S025, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2024年 / 109卷 / 09期
关键词：
thyroid eye disease; teprotumumab; MANAGEMENT;
D O I：
10.1210/clinem/dgae052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e1802 / e1803
页数：2
相关论文
共 50 条
  • [31] Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"
    Perry, Julian D.
    Hwang, Catherine J.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 112 - 112
  • [32] The jury is still out on Borna disease virus
    Kitching, RP
    VETERINARY JOURNAL, 2001, 161 (01): : 5 - 6
  • [33] Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?
    Martel, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (06): : 567 - 570
  • [34] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Yu, Caroline Y.
    Simmons, Brittany A.
    Pham, Chau M.
    Shriver, Erin M.
    EYE, 2022, 36 (07) : 1500 - 1501
  • [35] Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Wolkow, Natalie
    Lee, Nahyoung Grace
    Freitag, Suzanne K.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : 187 - 191
  • [36] Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
    Ho, Tiffany C.
    Maamari, Robi N.
    Kossler, Andrea L.
    Sears, Connie M.
    Freitag, Suzanne K.
    Reshef, Edith R.
    Shinder, Roman
    Rootman, Daniel B.
    Diniz, Stefania B.
    Kahana, Alon
    Schlachter, Dianne
    Do, Thai H.
    Kally, Peter
    Turner, Sara
    Mokhtarzadeh, Ali
    Harrison, Andrew R.
    Hwang, Christopher J.
    Kim, Hee Joon
    Avila, Sarah A.
    Thomas, Dilip A.
    Magazin, Maja
    Wester, Sara T.
    Lee, Wendy W.
    Clauss, Kevin D.
    Holds, John B.
    Sniegowski, Matthew
    Compton, Christopher J.
    Briggs, Christian
    Malik, Amina I.
    Lucarelli, Mark J.
    Burkat, Cat N.
    Patel, Luv G.
    Couch, Steven M.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (02): : 150 - 155
  • [37] Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report
    Singh, Gurdeep
    Taylor, Brittany
    Michalek, Samantha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [38] Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Perros, Petros
    Hegedus, Laszlo
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [39] Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
    Ugradar, Shoaib
    Braun, Jenna
    Wang, Yao
    Zimmerman, Erin
    Douglas, Raymond S.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2021, 9 (09) : E3809
  • [40] Teprotumumab for thyroid eye disease: early response is not required for benefit
    Shoaib Ugradar
    Yao Wang
    Tunde Mester
    George J. Kahaly
    Raymond S. Douglas
    Eye, 2022, 36 : 1403 - 1408
12345